Caricamento...
Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer
BACKGROUND: The neddylation pathway is overactivated in human cancers. Inhibition of neddylation pathway has emerged as an attractive anticancer strategy. The mechanisms underlying neddylation overactivation in cancer remain elusive. MLN4924/Pevonedistat, a first-in-class NEDD8-activating enzyme (NA...
Salvato in:
| Pubblicato in: | EBioMedicine |
|---|---|
| Autori principali: | , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6642072/ https://ncbi.nlm.nih.gov/pubmed/31208947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.06.005 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|